Patient-level meta-analysis of randomized trials of aromatase inhibitors (AI) versus tamoxifen (Tam).

Forbes JF.; Dowsett M.; Bradley R.; Ingle JN.; Aihara T.; Bliss JM.; Boccardo FM.; Coates AS.; Coombes RC.; Cuzick JM.; Dubsky PC.; Gnant M.; Kaufmann M.; Kilburn LS.; Perrone F.; Rea D.; Thurlimann BJK.; Van De Velde CJH.; Davies C.; Gray RG.; AIOG E.

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Patient-level meta-analysis of randomized trials of aromatase inhibitors (AI) versus tamoxifen (Tam).

Forbes JF., Dowsett M., Bradley R., Ingle JN., Aihara T., Bliss JM., Boccardo FM., Coates AS., Coombes RC., Cuzick JM., Dubsky PC., Gnant M., Kaufmann M., Kilburn LS., Perrone F., Rea D., Thurlimann BJK., Van De Velde CJH., Davies C., Gray RG., AIOG E.

Original publication

DOI

10.1200/jco.2014.32.15_suppl.529

Type

Conference paper

Publication Date

20/05/2014

Volume

32